Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMILE IV: zofenopril versus ramipril with aspirin after acute myocardial infarction
2004-001150-88Phase 3Completed
- Sponsor
- Menarini Group
- Start
- Mar 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of zofenopril, ramipril and aspirin in myocardial infarction (MI) and left ventricular systolic dysfunction (LVSD) (2 arms), sponsored by Menarini Group. Primary endpoint: 1-year cardiovascular mortality and morbidity. Started Mar 2005; status: completed.
02
Drugs
zofenoprilramiprilaspirin
03
Conditions
myocardial infarction (MI)left ventricular systolic dysfunction (LVSD)
Beyond the preview
Go deeper on 2004-001150-88.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001150-88.